Extensive Macular Atrophy With Pseudodrusen (EMAP)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Extensive Macular Atrophy With Pseudodrusen (EMAP) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (2 shown)

Active — Not RecruitingPhase 1/2

NCT07341919

Subtenon Autologous Platelet-Rich Plasma in Inherited and Degenerative Retinal Diseases

his prospective, comparative pilot study investigates the safety and functional outcomes of subtenon autologous platelet-rich plasma (PRP) in patients with Reti…

Brazil30 participantsStarted 2025-01-04

Treatment: Subtenon Injection of Autologous Platelet-Rich Plasma

Active — Not RecruitingPhase 1/2

NCT07348588

Intravitreal Adalimumab in Inherited and Degenerative Retinal Diseases

This prospective, comparative pilot study investigates the safety and functional outcomes of intravitreal adalimumab (ADA) in patients with Retinitis Pigmentosa…

Brazil30 participantsStarted 2024-03-01

Treatment: Intravitreal Adalimumab